Low-molecular-weight Heparin During Pregnancy

By Bazzan M.   Donvito V.  

Thrombosis Research, Vol. 101, Iss. 1, 2001-01 ,pp. : 175-186

Elsevier

Access to resources Recommend Favorite

Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits

By Tazawa S.   Ichikawa K.   Misawa K.   Fukuyama J.   Hamano S.   Miyata H.   Sakuragawa N.  

Thrombosis Research, Vol. 80, Iss. 5, 1995-12 ,pp. : 391-398

Elsevier

Access to resources Recommend Favorite

Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin

By Hansen J.-B.   Naalsund T.   Sandset P.M.   Svensson B.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 413-417

Elsevier

Access to resources Recommend Favorite

Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI) - Insight into its possible mechanism of action

By Hansen J.-B.   Sandset P.M.  

Thrombosis Research, Vol. 91, Iss. 4, 1998-08 ,pp. : 177-181

Elsevier

Access to resources Recommend Favorite

Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat

By Celasco Giuseppe   Moro Luigi   Bozzella Roberta   Mangano Katia   Quattrocchi Cinzia   Aiello Caterina   Donia Marco   Fagone Paolo   Marco Roberto  

Digestive Diseases and Sciences, Vol. 54, Iss. 1, 2009-01 ,pp. : 193-194

Springer Publishing Company

Access to resources Recommend Favorite